Adjuvant therapy for stage II melanoma: the need for further studies
European Journal of Cancer · 2023-08 · 189 · 112914
DOI: 10.1016/j.ejca.2023.05.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023-08. Verfasst von Rebecca Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK; The University of Manchester, Division of Cancer Sciences, Manches…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NHMRC, University of Sydney.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK; The University of Manchester, Division of Cancer Sciences, Manchester, UK.
- University of Perugia, Perugia, Italy; Ospedale Papa Givoanni XXIII, Bergamo, Italy.
- Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.
- University Medical Center Utrecht & Princess Maxima Center, Utrecht, the Netherlands; Comprehensive Cancer Center München, Technical University München & Ludwig Maximiliaan University, München, Germany.
- Comprehensive Cancer Center München, Technical University München & Ludwig Maximiliaan University, München, Germany; Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Royal Prince A…
- Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia.
Förderung
- Wellcome Trust
- NHMRC
- University of Sydney
Zitieren
APA
Lee, R., Mandala, M., Long, G. V., Eggermont, A. M. M., van Akkooi, A. C. J., Sandhu, S., Garbe, C., & Lorigan, P. (2023). Adjuvant therapy for stage II melanoma: the need for further studies. European Journal of Cancer, 189, 112914. https://doi.org/10.1016/j.ejca.2023.05.003
Vancouver
Lee R, Mandala M, Long GV, Eggermont AMM, van Akkooi ACJ, Sandhu S, et al. Adjuvant therapy for stage II melanoma: the need for further studies. European Journal of Cancer. 2023;189:112914. doi:10.1016/j.ejca.2023.05.003
BibTeX
@article{Lee2023,
author = {Lee, Rebecca and Mandala, Mario and Long, Georgina V and Eggermont, Alexander M M and van Akkooi, Alexander C J and Sandhu, Shahneen and Garbe, Claus and Lorigan, Paul},
title = {Adjuvant therapy for stage II melanoma: the need for further studies},
journal = {European Journal of Cancer},
year = {2023},
volume = {189},
pages = {112914},
doi = {10.1016/j.ejca.2023.05.003}
}
EUVIMED